Top Markets
#1 Islamic Coin Islamic Coin +154.46%
#2 PulseChain PulseChain +48.38%
#3 Ergo Ergo +29.15%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.40%
#5 RedStone RedStone +16.30%
#6 SkyAI SkyAI +10.37%
#7 Lighter Lighter +9.20%
#8 OPENLOOT OPENLOOT +8.93%
#9 Siren Siren +8.92%
#10 MarsCoin MarsCoin +8.84%
Coin of the day
Islamic Coin Islamic Coin
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Biora Therapeutics, Inc. Biora Therapeutics, Inc.

Biora Therapeutics, Inc.

PROG
Peringkat dalam Saham #27722
Biora Therapeutics, Inc., a biotechnology firm, focuses on the development and... Biora Therapeutics, Inc., a biotechnology firm, focuses on the development and commercialization of molecular diagnostic products within the United States. Its research and development efforts include targeted oral delivery systems for biotherapeutics, such as PGN-600, an oral liquid formulation of tofacitinib for ulcerative colitis, and PGN-001, an orally administered variant of adalimumab also targeting ulcerative colitis. Beyond this, the company is advancing systemic oral biotherapeutic delivery, exemplified by PGN-OB, which combines an adalimumab variant with their Oral Biotherapeutics Delivery System (OBDS) for inflammatory conditions, and PGN-OB2, pairing a GLP-1 receptor agonist with the OBDS for Type 2 diabetes. Biora Therapeutics also creates innovative diagnostic tools, including the Recoverable Sampling System – an ingestible smart capsule engineered to autonomously locate, collect, and preserve samples from the GI tract for analysis – and PIL Dx, another ingestible smart capsule designed to sample, measure, and transmit data wirelessly. A collaboration with Ionis Pharmaceuticals is underway to assess the OBDS platform for delivering antisense oligonucleotides. Founded in 2010 as Ascendant MDX, Inc., the company adopted the name Progenity, Inc. in November 2013, prior to becoming Biora Therapeutics, Inc. Its headquarters are located in San Diego, California.
Harga Saham
$0.8845
Terakhir disinkronkan: 2022-05-06
Kapitalisasi Pasar
$31.01M
Perubahan (1 hari)
-3.47%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Biora Therapeutics, Inc. (PROG)

Kategori

Healthcare
Pendapatan untuk Biora Therapeutics, Inc. (PROG)
Pendapatan pada Aug 2026 TTM: 0
Menurut laporan keuangan terbaru dari Biora Therapeutics, Inc., pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Biora Therapeutics, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH